Investigation of generic ‘cartel’ expands to 300 drugs

Washington Post

9 December 2018 - Executives at more than a dozen generic drug companies had a form of shorthand to describe how they conducted business, insider lingo worked out over steak dinners, cocktail receptions and rounds of golf.

The “sandbox,” according to investigators, was the market for generic prescription drugs, where everyone was expected to play nice.

“Fair share” described dividing up the sales pie to ensure that each company reaped continued profits. “Trashing the market” was used when a competitor ignored these unwritten rules and sold drugs for less than agreed-upon prices.

Read Washington Post article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Pricing , Generic medicine